Trial Profile
A pharmacokinetic study of treprostinil in patients with hepatic impairment
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Dec 2015
Price :
$35
*
At a glance
- Drugs Treprostinil (Primary)
- Indications Pulmonary arterial hypertension
- Focus Adverse reactions; Pharmacokinetics
- 04 Dec 2015 New trial record